FR2948567B1 - Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera - Google Patents

Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera

Info

Publication number
FR2948567B1
FR2948567B1 FR0903781A FR0903781A FR2948567B1 FR 2948567 B1 FR2948567 B1 FR 2948567B1 FR 0903781 A FR0903781 A FR 0903781A FR 0903781 A FR0903781 A FR 0903781A FR 2948567 B1 FR2948567 B1 FR 2948567B1
Authority
FR
France
Prior art keywords
ciguatera
treat
derivatives
rosmarinic acid
rosmarinic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR0903781A
Other languages
English (en)
Other versions
FR2948567A1 (fr
Inventor
Dominique Laurent
Serge Pauillac
Mireille Chinain
Taiana Darius
Roine Shilpa Kumar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Louis Malarde Fr
Institut de Recherche pour le Developpement IRD
Original Assignee
Inst De Rech Pour Le Dev
Institut de Recherche pour le Developpement IRD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0903781A priority Critical patent/FR2948567B1/fr
Application filed by Inst De Rech Pour Le Dev, Institut de Recherche pour le Developpement IRD filed Critical Inst De Rech Pour Le Dev
Priority to PCT/FR2010/000527 priority patent/WO2011012780A1/fr
Priority to US13/388,029 priority patent/US9060985B2/en
Priority to AU2010277458A priority patent/AU2010277458B2/en
Priority to EP10747916A priority patent/EP2459188A1/fr
Priority to JP2012522199A priority patent/JP5995235B2/ja
Publication of FR2948567A1 publication Critical patent/FR2948567A1/fr
Priority to AU2016273875A priority patent/AU2016273875A1/en
Application granted granted Critical
Publication of FR2948567B1 publication Critical patent/FR2948567B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0903781A 2009-07-31 2009-07-31 Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera Active FR2948567B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0903781A FR2948567B1 (fr) 2009-07-31 2009-07-31 Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera
US13/388,029 US9060985B2 (en) 2009-07-31 2010-07-21 Use of rosmarinic acid and the derivatives thereof to treat ciguatera
AU2010277458A AU2010277458B2 (en) 2009-07-31 2010-07-21 Use of rosmarinic acid and the derivatives thereof to treat ciguatera
EP10747916A EP2459188A1 (fr) 2009-07-31 2010-07-21 Utilisation de l'acide rosmarinique et de ses dérivés pour traiter la ciguatéra
PCT/FR2010/000527 WO2011012780A1 (fr) 2009-07-31 2010-07-21 Utilisation de l'acide rosmarinique et de ses dérivés pour traiter la ciguatéra
JP2012522199A JP5995235B2 (ja) 2009-07-31 2010-07-21 シガテラを治療するためのロスマリン酸及びその誘導体の使用
AU2016273875A AU2016273875A1 (en) 2009-07-31 2016-12-13 Use of rosmarinic acid and the derivatives thereof to treat ciguatera

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0903781A FR2948567B1 (fr) 2009-07-31 2009-07-31 Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera

Publications (2)

Publication Number Publication Date
FR2948567A1 FR2948567A1 (fr) 2011-02-04
FR2948567B1 true FR2948567B1 (fr) 2017-11-03

Family

ID=41339492

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0903781A Active FR2948567B1 (fr) 2009-07-31 2009-07-31 Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera

Country Status (6)

Country Link
US (1) US9060985B2 (fr)
EP (1) EP2459188A1 (fr)
JP (1) JP5995235B2 (fr)
AU (2) AU2010277458B2 (fr)
FR (1) FR2948567B1 (fr)
WO (1) WO2011012780A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102605187B1 (ko) * 2021-04-01 2023-11-23 한양대학교 에리카산학협력단 배암차즈기 추출물 또는 이의 유래 화합물을 유효성분으로 포함하는 근위축 예방 또는 치료용 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3734999A (en) * 1998-05-16 1999-12-06 Mogam Biotechnology Research Institute Use of rosmarinic acid and derivatives thereof as an immunosuppressant or an inhibitor of sh2-mediated process
WO2005027903A1 (fr) * 2003-09-19 2005-03-31 Univesity Of North Carolina At Derives de polyether brevetoxine pour le traitement d'empoisonnements neurotoxiques par les crustaces et de la ciguatera
EP1664056B1 (fr) * 2003-09-19 2010-03-03 University of North Carolina at Wilmington Polyethers pentacycliques fusionnes

Also Published As

Publication number Publication date
US9060985B2 (en) 2015-06-23
AU2010277458B2 (en) 2017-01-12
US20120196929A1 (en) 2012-08-02
JP2013500953A (ja) 2013-01-10
JP5995235B2 (ja) 2016-09-21
AU2016273875A1 (en) 2017-01-05
FR2948567A1 (fr) 2011-02-04
AU2010277458A1 (en) 2012-03-01
EP2459188A1 (fr) 2012-06-06
WO2011012780A1 (fr) 2011-02-03

Similar Documents

Publication Publication Date Title
FR24C1024I1 (fr) Combinaisons du dolutégravir et de la lamivudine destinées au traitement de l'infection au vih
FR2942719B1 (fr) Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
HK1243630A1 (zh) 1-甲基-n-(2，6-二甲苯基)-2-哌啶甲酰胺的皮膚用藥物組合物及其使用方法
FR2997845B1 (fr) Procede de lissage des cheveux a partir d'une composition contenant de l'acide glyoxylique et/ou un de ses derives
BR112012031548A2 (pt) remoção de compostos fisiologicamente ativos em água residuais
FR2902324B1 (fr) Utilisation d'acide ellagique pour le traitement de la canitie
FR2950247B1 (fr) Utilisation de l'acide ascorbique pour deformer des fibres keratiniques
SMT201600147B (it) Metodi per migliorare l'espressione di proteine ricombinanti
FR2981572B1 (fr) Compositions pharmaceutiques d'acide ursodesoxycholique
FR2928919B1 (fr) Procede de preparation de l'acide difluoroacetique et de ses sels
FR2956808B1 (fr) Utilisation de l'acide ellagique comme agent anti-pelliculaire.
FR2995784B1 (fr) Composition cosmetique sous forme d'emulsion et procede de traitement cosmetique
FR2912657B1 (fr) Utilisation de lactobacillus casei pour renforcer la protection induite par la vaccination anti-grippale.
FR2963237B1 (fr) Nouvelle composition pharmaceutique utile pour prevenir ou traiter l'hypotension arterielle peroperatoire chez l'etre humain
EP3138850B8 (fr) Compositions de l'acide désoxycholique et 10% d'eau déminéralisée dans l'éthanol, pour la purification de l'acide désoxycholique
FR2993141B1 (fr) Utilisation de l'acide 4-phenylbutyrique pour ameliorer la tolerance des plantes aux bioagresseurs
FR2988096B1 (fr) Production d'acide eicosapentaenoique et/ou d'acide arachidonique en mode mixotrophe par euglena
FR2947264B1 (fr) Procedure de preparation de l'acide difluoroacetique
FR2998894B1 (fr) Procede de fractionnement d'algues et utilisation des molecules obtenues
FR2992219B1 (fr) Composition pour le traitement de l'hypocalcemie chez les ruminants
FR2965278B1 (fr) Procede d'obtention in vitro ou ex vivo de chondrocytes et leurs utilisations
FR2948567B1 (fr) Utilisation de l'acide rosmarinique et de ses derives pour traiter la ciguatera
BRPI0914639A2 (pt) método de tratamento de abordagens de poços de armazenamento de gás ácido
FR2944786B1 (fr) Utilisation d'homopolymeres de l'acide maleique et de ses sels comme agents inhibiteurs de tartre et anti-adherence.
FR2985529B1 (fr) Caniveaux hydrauliques de drainage et d'evacuation des eaux de ruissellement

Legal Events

Date Code Title Description
TQ Partial transmission of property

Owner name: INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT, FR

Effective date: 20140624

Owner name: INSTITUT LOUIS MALARDE, FR

Effective date: 20140624

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8

PLFP Fee payment

Year of fee payment: 9

PLFP Fee payment

Year of fee payment: 10

PLFP Fee payment

Year of fee payment: 11

PLFP Fee payment

Year of fee payment: 12

PLFP Fee payment

Year of fee payment: 13

PLFP Fee payment

Year of fee payment: 14

PLFP Fee payment

Year of fee payment: 15

PLFP Fee payment

Year of fee payment: 16